Business
Medicare Expands Coverage for Obesity Drugs
Medicare will now cover obesity drugs for the first time, potentially benefiting millions of patients and expanding access to medications previously unavailable to seniors. This move could boost sales for pharmaceutical companies like Novo Nordisk and Eli Lilly.
Coverage timeline — 1 article
CNBC
The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were previously out of reach for seniors.
2026-06-30 09:00 UTC